The inverse correlations between metformin dose and NLR (Figure 7B), PLR (Figure 7C), SII (Figure 7D), and cTn I (Figure 7B) confirm metformin’s cadioprotective effects by suppressing inflammation in the DTC/+T2DM group. This evidence concerns the gene TNNI3 and type 2 diabetes mellitus.